Diabetes mellitus type 2 group I Atherosclerosis group II Control group (A+B) (C+D) anti- HSP 60/65 [ng/ml] 55.67 ± 65.43 82.98 ± 111.18 26.09 ± 13.85 significance A+B vs. C+D; NS A+B vs. contr; p<0.05 C+D vs. contr; p<0.01   Results are expressed as mean ± standard deviation. NS: Not Statistically Significant

Table 4: The concentration of anti-HSP 60/65 antibody in the serum of patientswith diabetic macrovascular disease and of patients with atherosclerosis without disorders of carbohydrate metabolism.